Sunshine Biopharma Inc Warrant
SBFMW
5 hedge funds and large institutions have $53.3K invested in Sunshine Biopharma Inc Warrant in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
302% more capital invested
Capital invested by funds: $13.3K → $53.3K (+$40K)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
67% more funds holding
Funds holding: 3 → 5 (+2)
0.44% more ownership
Funds ownership: 0.14% → 0.58% (+0.44%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$37.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$14K |
| 3 |
CS
Clear Street
New York
|
+$180 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$90 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.46K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $31.4K | +$37.3K | +83,132 | New |
|
|
2
Citadel Advisors
Miami,
Florida
| $15K | +$14K | +31,148 | New |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $5.91K | -$5.46K | -12,154 | -50% |
|
|
CS
4
Clear Street
New York
| $898 | +$180 | +400 | +20% |
|
|
5
Bank of America
Charlotte,
North Carolina
| $113 | +$90 | +200 | +200% |
|
SBFMW Hedge Fund Activity: Q2 2023 in Review
5 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Inc Warrant (SBFMW) for Q2 2023, worth a combined $53.3K — up 302% from $13.3K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new SBFMW positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $37.3K. The largest seller was Susquehanna International Group, cutting an estimated $5.46K.
- 5 institutional investors held Sunshine Biopharma Inc Warrant (SBFMW) as of Q2 2023, up from 3 in Q1 2023.
- Funds reported $53.3K of Sunshine Biopharma Inc Warrant stock for Q2 2023, up 302% quarter-over-quarter.
- 2 funds opened new Sunshine Biopharma Inc Warrant positions in Q2 2023 and 0 closed out, a net change of +2 holders.
- The largest Sunshine Biopharma Inc Warrant buyer in Q2 2023 was UBS Group, an estimated $37.3K added.
- The largest Sunshine Biopharma Inc Warrant seller in Q2 2023 was Susquehanna International Group, an estimated $5.46K sold.
Based on aggregated 13F filings for Q2 2023.